VRTX - VERTEX PHARMACEUTICALS INC / MA
488.95
0.230 0.047%
Share volume: 37,678
Last Updated: Wed 05 Feb 2025 07:30:09 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.07%
PREVIOUS CLOSE
CHG
CHG%
$488.72
0.23
0.05%
Summary score
69%
Profitability
95%
Dept financing
7%
Liquidity
64%
Performance
60%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
6.63%
Return on assets
5.84%
Return on sales
43.41%
Return on invested capital
34.89%
Total debt ratio
24.67%
Debt ratio change over timeo
-0.06%
Current Ratio
4.18%
Quick Ratio
4.01%
Cash Position Ratio
3.27%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
5.91%
Return on assets
4.97%
Return on sales
42.59%
Return on invested capital
23.7%
Total debt ratio
24.56%
Debt ratio change over timeo
-0.62%
Current Ratio
3.64%
Quick Ratio
3.42%
Cash Position Ratio
2.77%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
5.93%
Return on assets
5.09%
Return on sales
45.2%
Return on invested capital
16.09%
Total debt ratio
22.46%
Debt ratio change over time
-1.48%
Current Ratio
3.5%
Quick Ratio
3.29%
Cash Position Ratio
2.68%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-81.92%
Return on assets
-87.05%
Return on sales
-3.76%
Return on invested capital
-5.39%
Total debt ratio
-5.99%
Debt ratio change over time
-0.06%
Current Ratio
16.34%
Quick Ratio
15.7%
Cash Position Ratio
12.85%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VRTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 6.63% | 13.03% | 18.15% | 7.43% |
| Return on assets | 5.84% | 2.33% | 3.24% | 5.53% |
| Return on sales | 43.41% | 28.06% | 32.46% | 39.97% |
| Return on invested capital | 34.89% | 2.07% | 5.53% | 19.77% |
| Profitability | 84% | 46% | 62% | 71% |
| Total debt ratio | 24.67% | 90.46% | 90.54% | 26.45% |
| Debt ratio change over time | -0.06% | 435.59% | 17.23% | 1.17% |
| Dept financing | 7% | 50% | 26% | 7% |
| Current Ratio | 3.64% | 0.9% | 1.54% | 5.37% |
| Quick Ratio | 3.42% | 0.8% | 1.06% | 4.6% |
| Cash Position Ratio | 2.77% | 0.39% | 0.54% | 2.46% |
| Liquididy | 73% | 12% | 27% | 64% |
| Short-term ratios | VRTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 5.91% | 0% | 0% | 3.8% |
| Return on assets | 4.97% | 1.33% | 1.27% | 3.28% |
| Return on sales | 42.59% | 22.54% | 14.41% | 30.73% |
| Return on invested capital | 23.7% | 0% | 0% | 9.18% |
| Profitability | 100% | 20% | 15% | 60% |
| Total debt ratio | 24.56% | 93.47% | 94.09% | 21.77% |
| Debt ratio change over time | -0.62% | 0% | 0% | 1.41% |
| Dept financing | 7% | 25% | 25% | 31% |
| Current Ratio | 3.64% | 0.9% | 1.54% | 5.37% |
| Quick Ratio | 3.42% | 0.8% | 1.06% | 4.6% |
| Cash Position Ratio | 2.77% | 0.39% | 0.54% | 2.46% |
| Liquididy | 61% | 12% | 18% | 72% |